Related Experiment Video
Updated: Aug 9, 2026

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein
Z Deng1, J H Morse, S L Slager
1Department of Psychiatry, College of Physicians and Surgeons at Columbia University and the New York State Psychiatric Institute, New York, NY, USA.
Abstract:
Familial primary pulmonary hypertension is a rare autosomal dominant disorder that has reduced penetrance and that has been mapped to a 3-cM region on chromosome 2q33 (locus PPH1). The phenotype is characterized by monoclonal plexiform lesions of proliferating endothelial cells in pulmonary arterioles. These lesions lead to elevated pulmonary-artery pressures, right-ventricular failure, and death. Although primary pulmonary hypertension is rare, cases secondary to known etiologies are more common and include those associated with the appetite-suppressant drugs, including phentermine-fenfluramine. We genotyped 35 multiplex families with the disorder, using 27 microsatellite markers; we constructed disease haplotypes; and we looked for evidence of haplotype sharing across families, using the program TRANSMIT. Suggestive evidence of sharing was observed with markers GGAA19e07 and D2S307, and three nearby candidate genes were examined by denaturing high-performance liquid chromatography on individuals from 19 families. One of these genes (BMPR2), which encodes bone morphogenetic protein receptor type II, was found to contain five mutations that predict premature termination of the protein product and two missense mutations. These mutations were not observed in 196 control chromosomes. These findings indicate that the bone morphogenetic protein-signaling pathway is defective in patients with primary pulmonary hypertension and may implicate the pathway in the nonfamilial forms of the disease.
Insights
Familial primary pulmonary hypertension (PPH) is linked to chromosome 2q33. Mutations in the BMPR2 gene, affecting bone morphogenetic protein signaling, are identified as a cause of this rare disorder.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Molecular Biology
Background:
- Familial primary pulmonary hypertension (PPH) is a rare autosomal dominant disorder.
- PPH is characterized by proliferating endothelial cells in pulmonary arterioles, leading to elevated pulmonary-artery pressures and right-ventricular failure.
- Secondary pulmonary hypertension can be caused by factors like appetite-suppressant drugs.
Purpose of the Study:
- To identify the genetic locus and causative gene for familial primary pulmonary hypertension.
- To investigate the role of bone morphogenetic protein receptor type II (BMPR2) in PPH pathogenesis.
Main Methods:
- Genotyping of 35 multiplex families using 27 microsatellite markers.
- Haplotype analysis using the TRANSMIT program to identify shared regions.
- Sequencing of candidate genes, including BMPR2, using denaturing high-performance liquid chromatography.
Main Results:
- Suggestive evidence of haplotype sharing at markers GGAA19e07 and D2S307.
- Five mutations predicting premature protein termination and two missense mutations were identified in the BMPR2 gene in affected individuals.
- No BMPR2 mutations were found in 196 control chromosomes.
Conclusions:
- Mutations in the BMPR2 gene are a cause of familial primary pulmonary hypertension.
- Defects in the bone morphogenetic protein-signaling pathway are implicated in PPH.
- The findings suggest BMPR2 may also play a role in nonfamilial forms of pulmonary hypertension.
Related Concept Videos
Pleiotropy
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Hedgehog Signaling Pathway
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

